Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eloxatin + 5-FU/LV in Unresectable HCC
NCT00280618Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2004
- Primary completion
- Nov 2006
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of oxaliplatin in hepatocellular carcinoma (HCC), sponsored by Sanofi. Started Jul 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00280618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00280618.